Posted on August 19th, 2010 by
University of New Mexico Cancer Center researchers report in a new study that oncologists showed reluctance to give elderly patients a drug that had minor side effects but increased their chances of survival nearly sixfold. At the same time, the study found that the drug offers its greatest benefit to older patients who suffer from chronic myeloid leukemia, or CML, a relatively rare form of blood cancer that is diagnosed in about 4,500 new patients a year. Link
You must be logged-in to the site to post a comment.